Meanwhile, other studies proposed that GM-CSF may be useful as a novel vaccine adjuvant to combat human and animal virus, such as rabies virus (46), hantavirus (47, 48), and PRRSV (22, 23), while GM-CSF also acts for potential cancer vaccine (49). The gene discussed is CSF2; the disease is cancer.